These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24321200)

  • 41. Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer.
    Yang X; Gao F; Ma F; Ren Y; Chen H; Liang X; Han S; Xiong X; Pan W; Zhou C; Zhou L; Yang M
    Tumour Biol; 2016 Feb; 37(2):1693-8. PubMed ID: 26311051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples.
    Kloiber S; Czamara D; Karbalai N; Müller-Myhsok B; Hennings J; Holsboer F; Lucae S
    J Psychiatr Res; 2012 Aug; 46(8):973-9. PubMed ID: 22647524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of antidepressant efficacy-related SNPs among Taiwanese and four populations in the HapMap database.
    Chi MH; Lee SY; Chang HH; Yang YK; Lin E; Chen PS
    J Formos Med Assoc; 2011 Jul; 110(7):478-82. PubMed ID: 21742253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
    Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y
    Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder.
    Szczepankiewicz A; Leszczyńska-Rodziewicz A; Pawlak J; Rajewska-Rager A; Dmitrzak-Weglarz M; Wilkosc M; Skibinska M; Hauser J
    J Affect Disord; 2011 Nov; 134(1-3):138-44. PubMed ID: 21764460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic predisposition to advanced biological ageing increases risk for childhood-onset recurrent major depressive disorder in a large UK sample.
    Michalek JE; Kepa A; Vincent J; Frissa S; Goodwin L; Hotopf M; Hatch SL; Breen G; Powell TR
    J Affect Disord; 2017 Apr; 213():207-213. PubMed ID: 28233563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The serotonin transporter and the activity regulated cytoskeleton-associated protein genes in antidepressant response and resistance: 5-HTTLPR and other variants.
    Calabrò M; Fabbri C; Crisafulli C; Albani D; Forloni G; Kasper S; Sidoti A; Velardi E; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
    Hum Psychopharmacol; 2018 Nov; 33(6):e2682. PubMed ID: 30426571
    [No Abstract]   [Full Text] [Related]  

  • 48. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response.
    Yu YW; Chen TJ; Hong CJ; Chen HM; Tsai SJ
    Neuropsychopharmacology; 2003 Jun; 28(6):1182-5. PubMed ID: 12700687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.
    Unschuld PG; Ising M; Roeske D; Erhardt A; Specht M; Kloiber S; Uhr M; Müller-Myhsok B; Holsboer F; Binder EB
    Neuropsychopharmacology; 2010 Jun; 35(7):1583-92. PubMed ID: 20237460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders.
    Lee HJ; Cha JH; Ham BJ; Han CS; Kim YK; Lee SH; Ryu SH; Kang RH; Choi MJ; Lee MS
    Pharmacogenomics J; 2004; 4(1):29-33. PubMed ID: 14647404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonin transporter gene polymorphisms and treatment-resistant depression.
    Bonvicini C; Minelli A; Scassellati C; Bortolomasi M; Segala M; Sartori R; Giacopuzzi M; Gennarelli M
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):934-9. PubMed ID: 20450949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.
    Minelli A; Magri C; Barbon A; Bonvicini C; Segala M; Congiu C; Bignotti S; Milanesi E; Trabucchi L; Cattane N; Bortolomasi M; Gennarelli M
    Transl Psychiatry; 2015 Dec; 5(12):e687. PubMed ID: 26624926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
    Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
    Van Den Eede F; Venken T; Del-Favero J; Norrback KF; Souery D; Nilsson LG; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Mendlewicz J; Adolfsson R; Van Broeckhoven C; Claes SJ
    Psychiatry Res; 2007 Sep; 153(1):17-25. PubMed ID: 17599466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin.
    Illi A; Viikki M; Poutanen O; Setälä-Soikkeli E; Nuolivirta T; Kampman O; Leinonen E; Huhtala H; Mononen N; Lehtimäki T
    Psychiatr Genet; 2013 Feb; 23(1):33-5. PubMed ID: 23250003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Characterisation of three polymorphisms of the tryptophan hydroxylase 2 gene in a sample of Colombian population with major depressive disorder].
    Martínez-Idárraga A; Riveros-Barrera I; Sánchez R; Jaramillo LE; Calvo-Gómez JM; Yunis-Londoño JJ
    Rev Colomb Psiquiatr; 2017; 46(1):22-30. PubMed ID: 28193370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder.
    Kitzlerová E; Fišar Z; Lelková P; Jirák R; Zvěřová M; Hroudová J; Manukyan A; Martásek P; Raboch J
    Med Sci Monit; 2018 Apr; 24():2599-2619. PubMed ID: 29703883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
    Ising M; Lucae S; Binder EB; Bettecken T; Uhr M; Ripke S; Kohli MA; Hennings JM; Horstmann S; Kloiber S; Menke A; Bondy B; Rupprecht R; Domschke K; Baune BT; Arolt V; Rush AJ; Holsboer F; Müller-Myhsok B
    Arch Gen Psychiatry; 2009 Sep; 66(9):966-975. PubMed ID: 19736353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.